NeuroOne Medical Reports Three Large-Animal Procedures Using StereoCED

What Happened
NeuroOne Medical Technologies Corporation announced on August 27, 2026 (via Form 8-K) that three procedures in large animals were performed using its StereoCED™ platform. The company issued a press release describing the procedures; that release was filed as Exhibit 99.1 to the 8-K.

Key Details

• Date filed: August 27, 2026 (Current Report on Form 8-K, Item 8.01 – Other Events).
• Event: Three procedures conducted in large animals using the StereoCED™ platform.
• Disclosure: Company issued a press release, which is attached as Exhibit 99.1 to the 8-K.

Why It Matters
This notice documents a preclinical milestone for NeuroOne’s StereoCED platform, showing continued development activity and use in large-animal models. For investors, such updates help track technical progress and de-risking steps ahead of potential clinical trials or regulatory milestones; it is an operational development rather than a financial or management change.